Cingulate Inc. Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update
11 août 2022 06h45 HE
|
Cingulate Inc.
$5 Million of Non-Dilutive FinancingVeteran Biotech Executive Appointed to Board KANSAS CITY, Kan., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage...